Top Stories
ATAI Life Sciences Company, EmpathBio, Dives Into MDMA Derivatives, Calls MAPS’ Approach “MDMA 1.0” Through EmpathBio, ATAI Life Sciences says it will develop “safer” MDMA derivatives for patients with PTSD and calls the Multidisciplinary Association for Psychedelic Studies' (MAPS) approach "MDMA 1.0." MAPS' executive director, Rick Doblin, says that if that's the case, ATAI is "MDMA 0.5."
Through EmpathBio, ATAI Life Sciences says it will develop “safer” MDMA derivatives for patients with PTSD and calls the Multidisciplinary Association for Psychedelic Studies' (MAPS) approach "MDMA 1.0." MAPS' executive director, Rick Doblin, says that if that's the case, ATAI is "MDMA 0.5."
As COMPASS Pathways continues its attempts to build a psychedelic monopoly, Usona Institute keeps publishing open research
Since COMPASS Pathways filed for a controversial psilocybin patent in 2018, Usona Institute has consistently placed its research findings in the public domain.
Top Stories
Become a member
and support our work.
Coronavirus Conspiracy Theories in Psychedelia
Terence McKenna once mused, “Conspiracy theory is a kind of epistemological cartoon about reality.” Looking around at the world, things appear awfully cartoonish at the moment. We're joined by Psymposia Senior Writer, Russell Hausfeld, to discuss the propagation of coronavirus conspiracies, recent revelations about QAnon, and the likelihood that some "conspiracy" claims are simply warped articulations of systemic critique. 5G won't give you COVID-19, but it sure will help you download this episode faster.
Join Our Newsletter
Independent drug journalism. In your inbox.
Read the series
Corporadelic
A six part series on the intersection of psychedelics and capitalism, and the early investors making it happen.
Psychedelic Sisters in Arms
A series of personal stories on consent, gender, and sexual violence against women in psychedelic communities.
Popular Reads
Dear Psychedelic Researchers
The coronavirus has made it clear that psychedelic medicalization will not revolutionize mental healthcare without systemic socioeconomic change.
Join Our
Newsletter
Independent drug journalism. In your inbox.
Corporadelic
A series on the intersection of psychedelics and capitalism, and the early investors making it happen.
Popular Reads
PSYCHEDELIC SISTERS IN ARMS
A series of personal stories on consent, gender, and sexual violence against women in psychedelic communities.
